BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 27275748)

  • 1. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
    Tokmak A; Kokanali D; Timur H; Kuntay Kokanali M; Yilmaz N
    Gynecol Endocrinol; 2016 Nov; 32(11):926-930. PubMed ID: 27275748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome.
    Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A
    Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Mullerian hormone and insulin resistance in polycystic ovary syndrome.
    Fonseca HP; Brondi RS; Piovesan FX; Miklos TG; Aldrighi JM
    Gynecol Endocrinol; 2014 Sep; 30(9):667-70. PubMed ID: 24898132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-Müllerian hormone and insulin resistance in the main phenotypes of non-obese polycystic ovarian syndrome women in China.
    Tian X; Ruan X; Mueck AO; Wallwiener D; Wang J; Liu S; Yin D; Lu Y; Zhang Y; Wu H
    Gynecol Endocrinol; 2014 Nov; 30(11):836-9. PubMed ID: 25045796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Müllerian hormone gene polymorphism is associated with androgen levels in Chinese polycystic ovary syndrome patients with insulin resistance.
    Zheng MX; Li Y; Hu R; Wang FM; Zhang XM; Guan B
    J Assist Reprod Genet; 2016 Feb; 33(2):199-205. PubMed ID: 26732661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of insulin resistance and its relationship with hyperandrogenemia,anti-Müllerian hormone, inhibin A, inhibin B, and insulin-like peptide-3 levels in adolescent girls with polycystic ovary syndrome.
    Yetim Şahin A; Baş F; Yetim Ç; Uçar A; Poyrazoğlu Ş; Bundak R; Darendeliler F
    Turk J Med Sci; 2019 Aug; 49(4):1117-1125. PubMed ID: 31286756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between serum AMH and HOMA-IR among PCOS phenotypes.
    Wiweko B; Indra I; Susanto C; Natadisastra M; Hestiantoro A
    BMC Res Notes; 2018 Feb; 11(1):114. PubMed ID: 29426356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS).
    Park HT; Cho GJ; Ahn KH; Shin JH; Kim YT; Hur JY; Kim SH; Lee KW; Kim T
    Clin Endocrinol (Oxf); 2010 Jan; 72(1):26-31. PubMed ID: 19438903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS.
    Caglar GS; Kahyaoglu I; Pabuccu R; Demirtas S; Seker R
    Arch Gynecol Obstet; 2013 Oct; 288(4):905-10. PubMed ID: 23553200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
    Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
    Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
    Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is the plasma anti-Müllerian hormone (AMH) level associated with body weight and metabolic, and hormonal disturbances in women with and without polycystic ovary syndrome?
    Skałba P; Cygal A; Madej P; Dąbkowska-Huć A; Sikora J; Martirosian G; Romanik M; Olszanecka-Glinianowicz M
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):254-9. PubMed ID: 21752527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum AMH levels and insulin resistance in women with PCOS.
    Sahmay S; Aydogan Mathyk B; Sofiyeva N; Atakul N; Azemi A; Erel T
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():159-164. PubMed ID: 29605710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome.
    Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö
    J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women.
    Jahromi BN; Dabbaghmanesh MH; Bakhshaie P; Parsanezhad ME; Anvar Z; Alborzi M; Zarei A; Bakhshaei M
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in non-obese subfertile women with and without polycystic ovary syndrome.
    Nardo LG; Yates AP; Roberts SA; Pemberton P; Laing I
    Hum Reprod; 2009 Nov; 24(11):2917-23. PubMed ID: 19617605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].
    Parahuleva N; Pehlivanov B; Orbecova M; Deneva T; Uchikova E
    Akush Ginekol (Sofiia); 2013; 52 Suppl 1():16-23. PubMed ID: 24294740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
    Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-Mullerian hormone in the major phenotypes of polycystic ovary syndrome].
    Parahuleva N; Pehlivanov B; Orbecova M; Uchikova E; Ivancheva H
    Akush Ginekol (Sofiia); 2014; 53(5):22-7. PubMed ID: 25558667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.